Literature DB >> 33501647

CD8+ Tregs revisited: A heterogeneous population with different phenotypes and properties.

Veronika Niederlova1, Oksana Tsyklauri1,2, Tereza Chadimova1,3, Ondrej Stepanek1.   

Abstract

Regulatory T cells (Tregs) play a key role in the peripheral self-tolerance and preventing autoimmunity. While classical CD4+ Foxp3+ Tregs are well established, their CD8+ counterparts are still controversial in many aspects including their phenotypic identity and their mechanisms of suppression. Because of these controversies and because of only a limited number of studies documenting the immunoregulatory function of CD8+ Tregs in vivo, the concept of CD8+ Tregs is still not unanimously accepted. We propose that any T-cell subset considered as true regulatory must be distinguishable from other cell types and must suppress in vivo immune responses via a known mechanism. In this article, we revisit the concept of CD8+ Tregs by focusing on the characterization of individual CD8+ T-cell subsets with proposed regulatory capacity separately. Therefore, we review the phenotype and function of CD8+ FOXP3+ T cells, CD8+ CD122+ T cells, CD8+ CD28low/- T cells, CD8+ CD45RClow T cells, T cells expressing CD8αα homodimer and Qa-1-restricted CD8+ T cells to show whether there is sufficient evidence to establish these subsets as bona fide Tregs. Based on the intrinsic ability of CD8+ Treg subsets to promote immune tolerance in animal models, we elaborate on their potential use in clinics.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  Autoimmunity; CD8 T cells; Homeostasis; Regulatory T cells; Tolerance

Year:  2021        PMID: 33501647     DOI: 10.1002/eji.202048614

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  Tumor-infiltrating CD226+CD8+ T cells are associated with postoperative prognosis and adjuvant chemotherapeutic benefits in gastric cancer patients.

Authors:  Yu Zhang; Zhen-Xiong Zhao; Jian-Peng Gao; Ya-Kai Huang; Hua Huang
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-15       Impact factor: 4.322

Review 2.  Vasculitogenic T Cells in Large Vessel Vasculitis.

Authors:  Ryu Watanabe; Motomu Hashimoto
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

3.  Context-dependent effects of IL-2 rewire immunity into distinct cellular circuits.

Authors:  Carly E Whyte; Kailash Singh; James Dooley; Oliver T Burton; Meryem Aloulou; Lubna Kouser; Rafael Valente Veiga; Amy Dashwood; Hanneke Okkenhaug; Samira Benadda; Alena Moudra; Orian Bricard; Stephanie Lienart; Pascal Bielefeld; Carlos P Roca; Francisco José Naranjo-Galindo; Félix Lombard-Vadnais; Steffie Junius; David Bending; Masahiro Ono; Tino Hochepied; Timotheus Y F Halim; Susan Schlenner; Sylvie Lesage; Adrian Liston
Journal:  J Exp Med       Date:  2022-06-14       Impact factor: 17.579

4.  Accumulation of pTreg cells is detrimental in late-onset (aged) mouse model of multiple sclerosis.

Authors:  Weikan Wang; Rachel Thomas; Jiyoung Oh; Dong-Ming Su
Journal:  Aging Cell       Date:  2022-05-26       Impact factor: 11.005

Review 5.  The Regulatory-T-Cell Memory Phenotype: What We Know.

Authors:  Julia N Khantakova; Aleksey S Bulygin; Sergey V Sennikov
Journal:  Cells       Date:  2022-05-19       Impact factor: 7.666

Review 6.  Harnessing CD8+CD28- Regulatory T Cells as a Tool to Treat Autoimmune Disease.

Authors:  Sabrina Ceeraz; Charlotte R Thompson; Richard Beatson; Ernest H Choy
Journal:  Cells       Date:  2021-11-01       Impact factor: 6.600

Review 7.  The New Old CD8+ T Cells in the Immune Paradox of Pregnancy.

Authors:  Lilja Hardardottir; Maria Victoria Bazzano; Laura Glau; Luca Gattinoni; Angela Köninger; Eva Tolosa; Maria Emilia Solano
Journal:  Front Immunol       Date:  2021-11-16       Impact factor: 7.561

Review 8.  CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications.

Authors:  Motahareh Arjomandnejad; Acadia L Kopec; Allison M Keeler
Journal:  Biomedicines       Date:  2022-01-26

9.  Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells.

Authors:  Motahareh Arjomandnejad; Katelyn Sylvia; Meghan Blackwood; Thomas Nixon; Qiushi Tang; Manish Muhuri; Alisha M Gruntman; Guangping Gao; Terence R Flotte; Allison M Keeler
Journal:  Mol Ther Methods Clin Dev       Date:  2021-10-28       Impact factor: 5.849

10.  Quantitative Analyses Reveal How Hypoxia Reconfigures the Proteome of Primary Cytotoxic T Lymphocytes.

Authors:  Sarah H Ross; Christina M Rollings; Doreen A Cantrell
Journal:  Front Immunol       Date:  2021-09-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.